Available online on 15.06.2025 at http://jddtonline.info
Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2025 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Case Report
Traditional Wisdom Meets Chronic Disease: Unani Success in Managing Psoriasis with Zimad and Leech Therapy-A Case Report
Umme Ayman 1*, Shaik Adeena Parveen 2, Firdous K Fakeha ³
1 Assistant Professor, Department of Regimenal Therapies, National Institute of Unani Medicine, Bengaluru, Karnataka, India.
2 PG Scholar, Department of Regimenal Therapies, National Institute of Unani Medicine, Bengaluru, Karnataka, India.
3 Research Associate, Clinical Research Unit (Unani), Central Council for Research in Unani Medicine, Bengaluru
|
Article Info: _______________________________________________ Article History: Received 20 March 2025 Reviewed 03 May 2025 Accepted 26 May 2025 Published 15 June 2025 _______________________________________________ Cite this article as: Ayman U, Parveen SA, Fakeha FK, Traditional Wisdom Meets Chronic Disease: Unani Success in Managing Psoriasis with Zimad and Leech Therapy-A Case Report, Journal of Drug Delivery and Therapeutics. 2025; 15(6):1-5 DOI: http://dx.doi.org/10.22270/jddt.v15i6.7214 _______________________________________________ *Address for Correspondence: Shaik Adeena Parveen, PG Scholar, Department of Regimenal Therapies, National Institute of Unani Medicine, Bengaluru, Karnataka, India. |
Abstract _______________________________________________________________________________________________________________ Background: Psoriasis is a chronic, immune-mediated inflammatory skin disorder marked by erythematous plaques with silvery-white scales, significantly affecting patients’ physical and psychological well-being. Conventional therapies, while often effective in symptom control, can result in side effects or limited long-term efficacy. Unani medicine, a traditional holistic system, incorporates unique therapeutic modalities such as Zimad (topical applications) and Taleeq (leech therapy), which aim to restore humoral balance and detoxify the body. Objective: To evaluate the efficacy of Unani therapeutic interventions, specifically Zimad and Leech therapy, in a patient with chronic psoriasis unresponsive to conventional treatments. Methods: A 45-year-old female with 15-year history of psoriasis was presented with widespread lesions, erythema, scaling, and pruritus. The patient was treated with Unani regimens like Taleeq (Leech Therapy) in which, two leeches over the affected site were applied twice a week for 10 sittings along with herbal Zimad containing anti-inflammatory and keratolytic properties was applied twice daily. Clinical assessment was performed at baseline, 21st day and 35th day using Psoriasis Area and Severity Index (PASI) and Dermatological Life Quality Index (DLQI). Results: Marked improvement was observed after 35 days of treatment. Erythema, scaling, and itching were significantly reduced, with a notable decrease in PASI and DLQI scores. The patient reported improved quality of life and no adverse effects. The outcome suggests potential benefits of Unani therapy in managing psoriasis. Conclusion: This case demonstrates that Unani therapies, particularly Zimad and Taleeq, may offer an effective complementary approach for managing chronic psoriasis, especially in patients who are unresponsive to conventional treatments. These modalities appear to support symptom relief through detoxification and humoral correction without adverse events. Larger-scale clinical studies are warranted to validate these findings. Keywords: Psoriasis, Taqashshur al-Jild, Zimad, Taleeq, Leech Therapy, Unani |
INTRODUCTION
The term Psoriasis is derived from the Greek word “psora”, meaning itch.1 Psoriasis is a chronic, immune-mediated, non-communicable inflammatory disorder predominantly affecting the skin and joints, clinically presenting as well-demarcated erythematous plaques with hyperkeratotic, micaceous scaling, often resulting in the formation of thick, crusted silvery scales and desquamative lesions.2 In India, the overall incidence was estimated as 1.02% with the highest incidence among the age group of 20-39 years.3 Its prevalence is 0.33%-0.6% in different races,4,5 and affects around 125 million people worldwide. With the understanding of the biological nature of psoriasis, it has been recognized as an autoimmune disease with significant impacts on health implications extending beyond the skin.6
In classical Unani literature, psoriasis is termed “Taqashshur al-Jild”. It is a prevalent skin condition marked by excessive dryness and the formation of scales resembling fish scales. The condition worsens due to an imbalance of Akhlat caused by excessive heat (hiddat) and putrefaction of blood (ta'affun-i-dam), along with an impairment of bile (Safrā) and blood. It arises due to Ihtiraq-i- Sawdā, which has an irritant nature that damages the skin, leading to severe itching, roughness, and scaling. According to Razi and Majusi, an excess of Khilt-i-Ghaliz (abnormal sawdā) accumulates in the skin, disrupting its nourishment and function, ultimately causing the skin to deteriorate and shed in the form of scales. Unani scholars recommend avoiding sour and sweet foods in the diet to manage the condition.7
MATERIALS AND METHODS
A 45-year-old female patient visited the Outpatient Department (OPD) at the National Institute of Unani Medicine (NIUM) seeking Unani treatment for psoriasis, as conventional therapies had been ineffective. She underwent Leech Therapy and Zimad application for 35 days. The treatment response was assessed during each OPD visit using the Psoriasis Area and Severity Index (PASI) score and Dermatological Life Quality Index (DLQI), along with photographic documentation of the lesions taken at baseline and after treatment completion. The safety of the therapy was monitored through clinical evaluation for adverse effects at each follow-up, as well as laboratory investigations conducted both at baseline and after 35 days of treatment.
CASE REPORT
A 45-year-old female patient attended the Outpatient Department (OPD -28) at the National Institute of Unani Medicine (NIUM) with a 15-year history of red, scaly, and itchy plaques on the anterior aspects of both legs. Despite undergoing multiple modern treatments, she did not experience relief. On a friend’s recommendation, she sought treatment at NIUM, where the diagnosis was established based on her characteristic clinical presentation, detailed medical history, and thorough examination.
Past Medical History
The patient had no significant past medical history. She had no history of Hypertension, Diabetes mellitus, hypothyroidism, asthma, or any previous surgeries.
Family History
There was no significant family history.
Clinical Examination
General Physical Examination
The patient was a well-nourished female with a moderate build and wheatish complexion. There was no evidence of palpable lymph nodes, jaundice, pallor, or edema. Her vitals were within normal limits.
Vital Signs
Blood Pressure: 120/80 mmHg
Pulse Rate: 79 beats per minute
Respiratory Rate: 21 breaths per minute
Temperature: Afebrile
Systemic Examination
CNS – Conscious and Coherent
CVS - S1 & S2 audible, No cardiac murmurs
RS – Chest is bilaterally clear on auscultation
Abdomen- Soft and Non-tender
Musculoskeletal examination - The range of motion was normal in all joints, with no signs of Joint swelling, tenderness, effusion, or deformities.
Dermatological examination –
Generalized, symmetrical, well-demarcated, medium to large erythematous plaques with silvery white scales were found over the anterior aspect of both legs (Figure1)
Auspitz sign (pinpoint bleeding within the lesion on the removal of psoriatic scale) was positive.
Candle-grease sign (when scratched, psoriatic scales fall off revealing a shiny candle-like surface) was positive.
PASI Score (Psoriasis Area and Severity Index) was 11.2, revealing that erythema (redness), induration (thickness), and desquamation (scaling) were all severe, with involvement of about 45% body surface area (BSA)
INTERVENTION
Two leeches over the affected site were applied twice a week for ten sittings along with Zimad (Medicinal Paste) for local application twice daily up to 35 days, which was started from the next day of leech therapy.
Follow up
Patient was assessed three times. First assessment was done on 0th day and second assessment on 21st day and third on 35th day.
Zimad Preparation
A formulation was selected from the literature, consisting of five ingredients: Hina (Lawsonia inermis Linn.), Baloot (Quercus incana), Jouz-us-Saru (Casuarina equisetifolia), Gulnar (flowers of Punica granatum), and Post Anar (Punica granatum). These ingredients were taken in equal amounts, ground into a fine powder, and sieved. To prepare the Zimad (paste), Vinegar (Sirka) was boiled in a vessel, and the powdered ingredients were gradually incorporated while stirring continuously until a smooth, paste-like consistency was obtained.8,9,10
ASSESSMENT
1. Psoriasis Area and Severity Index (PASI)
The PASI combines assessments of 4 body areas: the head and neck (H), the upper limbs (UL), the trunk (T) and the lower limbs (LL).
The percentage of skin affected by psoriasis in each area is given a numerical score (A) representing the proportion involved: 1(0-9%), 2(10-29%), 3 (30-49%), 4 (50-69%), 5 (70-89%), or 6 (90-100%). Within each area (H, UL, T, LL) the severity of 3 plaque signs - Erythema (E), Thickness/Induration (I) and Desquamation/scaling (D)
PASI = 0.1(EH+IH+HH) AH + 0.2(EUL+IUL+HUL) AUL + 0.3(ET+IT+HT) AT + 0.4(ELL+ILL+HLL) ALL
|
TABLE 1- Improvement in PASI Score |
||
|
Visit |
PASI Score |
% Reduction |
|
Baseline (0th Day) |
11.2 |
00.00 |
|
1st Follow-up (21st Day) |
6 |
46.4 |
|
2nd Follow-up (35th Day) |
2.4 |
78.6 |
|
TABLE 2: Clinical assessment and improved features on subsequent follow-up |
|||
|
|
Erythema (E) |
Induration (I) |
Desquamation (D) |
|
Baseline (0th Day) |
++++ |
++++ |
++++ |
|
1st Follow-up (21st Day) |
+++ |
++ |
+++ |
|
2nd Follow-up (35th Day) |
+ |
+ |
+ |
++++ = Severe, +++ =moderate to severe, ++ =moderate, + = mild, - = negative
|
TABLE 3 - Dermatological Life Quality Index (DLQI) |
|||
|
S.No. |
Questionnaire |
Before Treatment |
After Treatment |
|
1 |
How itchy, sore, painful or stinging has your skin been? |
3 |
1 |
|
2 |
How embarrassed or self conscious have you been? |
1 |
0 |
|
3 |
How much has your skin interfered with you going shopping? |
0 |
0 |
|
4 |
How much has your skin influenced the clothes you wear? |
1 |
1 |
|
5 |
How much has your skin affected any social activities? |
0 |
0 |
|
6 |
How much has your skin made it difficult to do any sport? |
1 |
1 |
|
7 |
Has your skin prevented you from working or studying? |
0 |
0 |
|
8 |
How much has your skin created problem with your partner? |
0 |
0 |
|
9 |
How much has your skin caused any sexual difficulties? |
0 |
0 |
|
10 |
How much has your skin created problem in preparing food |
1 |
1 |
|
|
TOTAL |
7 |
4 |
Investigations
Hb, BT, CT, HIV, HbsAg, RBS
All the reports were within normal limits
Figure 1: Before Treatment Figure 2: After Treatment
Figure 3&4: Application of Leech over affected areas
DISCUSSION
Leech therapy has been utilized in medicinal practices since ancient Egypt and continues to be applied in modern reconstructive surgery. Galen advocated for its use in balancing humors, while the esteemed Greco-Arabic scholar Ibn Sina recommended leeching to extract blood from deeper tissues.
Psoriasis is an autoimmune disorder driven by T-cell activation, triggered by environmental factors. This activation leads to the release of cytokines, which accelerate keratinocyte proliferation and induce antigenic adhesion molecules in dermal blood vessels. These molecules further stimulate T cells, perpetuating the inflammatory cycle.
In this case study, the combined therapeutic efficacy of Unani medicine and leech therapy was assessed for the management of psoriatic lesions. The patient’s progress was evaluated using the Psoriasis Area and Severity Index (PASI). Notably, the PASI score showed a significant improvement, decreasing from 11.2 to 2.4, highlighting the potential benefits of this integrative approach.3
Leech therapy is a well-established biotherapeutic approach that derives its efficacy from the presence of numerous bioactive compounds in leech saliva. Key components such as Hirudin, Calin, Kallikrein inhibitors, histamine-like substances, Hyaluronidase, Collagenase, Pseudohirudin, Destabilase, and Lipase contribute to its therapeutic effects. The vasodilatory properties of these substances enhance blood circulation, while acetylcholine, a histamine-like compound, plays a crucial role in correcting microangiopathy. Additionally, leech therapy exhibits anesthetic properties, providing relief from itching. The presence of Bdellines and Egllins further enhances its anti-inflammatory effects, effectively reducing local erythema and inflammation. These multifaceted benefits make leech therapy a valuable tool in modern medical applications.11
Recent studies on Malaysian leeches have identified antioxidant properties in their saliva, which may contribute to the healing of psoriatic lesions. This is particularly relevant given recent findings indicating elevated levels of oxidized low-density lipoprotein (LDL) in such lesions. Furthermore, since psoriasis is an immune-mediated disorder, the immunomodulatory effects of leech saliva could also play a beneficial role in its management.12
Lawsonia inermis helps in managing psoriasis by modulating inflammatory pathways involving TNF-α, IL-1β, and VEGF (vascular endothelial growth factor), which play key roles in the disease's progression. Its natural anti-inflammatory and antioxidant properties can potentially reduce excessive cytokine activity, alleviating skin inflammation and irritation. By targeting these pro-inflammatory mediators, henna offers a promising complementary approach to psoriasis treatment.13
Quercus, has been recognized for its therapeutic potential in treating inflammatory conditions, particularly skin disorders. Its diverse bioactive constituents—including pedunculagin, ellagic acid, phenolic compounds, glycosides, flavonoids, gallic acid, galloyl derivatives, malic acid, hexa-hydroxy diphenyl, tannic acid, mucilage, quercin, and pectin—demonstrate potent anti-inflammatory, antioxidant, and regenerative properties. By modulating chemokine and cytokine activity in keratinocytes, Quercus shows promise as a natural treatment for chronic inflammatory skin diseases such as psoriasis and atopic dermatitis.14,15
Studies suggest that Punica granatum extracts may help treat psoriasis through anti-inflammatory and skin-restoring effects. Punicalagin, a key compound in pomegranate peel, reduced psoriasis-like symptoms in mice by inhibiting the NF-κB pathway and lowering IL-1β expression. Polysaccharides from pomegranate peel improved skin barrier function and suppressed inflammation by regulating FLG, AQP3, STAT3, and NF-κB pathways. In vitro studies showed that pomegranate-derived compounds inhibited thymidine phosphorylase, an enzyme linked to psoriasis. These findings highlight Punica granatum as a potential natural remedy for psoriasis.16
RESULTS
The integration of Zimad with Leech therapy demons-trated remarkable efficacy in alleviating psoriatic lesions. The treatment outcomes were objectively assessed using the Psoriasis Area and Severity Index (PASI) and Dermatological Life Quality Index (DLQI), revealing a substantial reduction in the PASI score from 11.2 to 2.4 and a decrease in DLQI from 7 to 4. This significant improvement reflects a marked decrease in erythema, scaling, and induration, highlighting the therapeutic potential of this integrative approach.
The Zimad, enriched with anti-inflammatory and keratolytic agents, played a pivotal role in restoring skin homeostasis, facilitating lesion resolution, and reducing hyperproliferation of keratinocytes. Simultaneously, leech therapy contributed through its unique bioactive components, particularly antioxidants and immune-modulatory compounds present in leech saliva. These factors potentially mitigated oxidative stress - recently linked to elevated oxidized low-density lipoproteins (LDL) in psoriatic plaques and modulated immune dysregulation, which is central to psoriasis pathogenesis.
The synergy between Unani pharmacotherapy and leech therapy underscores a novel, holistic approach to psoriasis management, leveraging traditional wisdom with modern scientific insights. This study provides compelling evidence for the revival of bio-integrative therapies in dermatological care. Further clinical trials with larger cohorts are warranted to validate these findings and explore their long-term efficacy.
CONCLUSION
Psoriasis is a chronic autoimmune inflammatory condition affecting the skin. According to the Unani system of medicine, various factors contribute to its development, including infections and imbalances in bodily humours, particularly Sawda (black bile) and Balgham (phlegm). Effective management aims to alleviate symptoms and prevent recurrence. The high cost, limited availability, and potential side effects of prolonged allopathic treatments pose significant challenges. Therefore, the search for safer and more effective anti-psoriatic therapies remains an active area of research.
Notably, Unani compound formulations along with Leech Therapy have demonstrated excellent tolerance and acceptability in patients, with no reported side effects. Significant improvements have been observed in both subjective and objective parameters, including the Psoriasis Area and Severity Index (PASI) and Dermatological Life Quality Index (DLQI). These findings suggest that Unani treatments could be a safe and effective alternative for managing psoriasis. However, further randomized clinical trials are necessary to establish their efficacy and introduce a novel therapeutic approach using Unani classical medicines.
Informed Consent: Written informed consent was obtained from the patient, and clinical data included in this case study were collected in compliance with the Declaration of Helsinki (2013).
Acknowledgement: All authors are thankful to the Director, Teachers and Staff of National Institute of Unani Medicine, Bengaluru for providing the necessary facilities.
Financial support and sponsorship: Nil
Conflict of Interest: There is no conflict of interest.
REFERENCES
1. Lone AH, Ahmad T and Naiyar AH. Clinical evaluation of efficacy of Maj'un Ushba and RoghanHindi in the management of psoriasis: A Randomized Single-Blind, Placebo-Controlled Study. Journal of Ayurveda & Integrative Medicine. 2011; 2(1): Pp.26 -31. https://doi.org/10.4103/0975-9476.78188 PMid:21731384 PMCid:PMC3121250
2. Qureshi MA, Bano H. Clinical observation of Unani medicine in the treatment of Psoriasis: A Case Study.
3. Tabasum H. EFFICACY OF UNANI MEDICATIONS AND TALEEQ (LEECH THERAPY) IN THE MANAGEMENT OF TAQASHSHUR JILD (PSORIASIS)-A CASE REPORT.
4. Arnold KA, Treister AD, Lio PA, Alenghat FJ. Association of Atherosclerosis Prevalence With Age, Race, and Traditional Risk Factors in Patients With Psoriasis. JAMA Dermatol 2019;155(5):622-3. https://doi.org/10.1001/jamadermatol.2018.5462 PMid:30785601 PMCid:PMC6506874
5. Jung KJ, Kim TG, Lee JW, Lee M, Oh J, Lee SE, et al. Increased Risk of Atherosclerotic Cardiovascular Disease Among Patients With Psoriasis in Korea: A 15-Year Nationwide Population-Based Cohort Study. J Dermatol (2019) 46(10):859-66. https://doi.org/10.1111/1346-8138.15052 PMid:31432567
6. Committee of Psoriasis, Dermatology Branch, Chinese Medical Association. Guidelines for the Diagnosis and Treatment of Psoriasis in China: 2019 Concise Edition. Int J Dermatol Venereol 2020;3(1):14-26. https://doi.org/10.1097/JD9.0000000000000074
7. al-Jild T. Effectiveness of Oral and Topical Unani Formulations in Taqashshur Al-Jild (Psoriasis): A Case Study. Indian Journal of Unani Medicine Vol. XIV. 2021 Jul(2):96-101.
8. Khan MA. Ramooz Azam (Persian version). 2nd ed. New Delhi: CCRUM; 2006.
9. Arzani MA. Tibb-e-Akbar (Urdu Translation by Hakeem Mohd Husain). New Delhi: Idara Kitab us Shifa; YNM.
10. Kabeerudin. Sharha-Asbab. New Delhi: Aijaz Publication House; 2007.
11. S M Abbas Zaidi, S S Jameel, F Zaman, Shazia Jilani, A Sultana, Shariq A Khan. A Systematic Overview of the Medicinal Importance of Sanguivorous Leeches. Alternative Medicine Review. 2011;16(1):59-65
12. Ghawi AM, Abdualkader AM, Merzouk A, Alaama M. Free Radical Scavenging Activity of the Medicinal Malaysian Leech Saliva Extract, Hirudinaria manillensis. J Bioequi Availab 2012; S14. https://doi.org/10.4172/jbb.S14-001
13. Nair AS, Sekar M, Gan SH, Kumarasamy V, Subramaniyan V, Wu YS, Mat Rani NN, Ravi S, Wong LS. Lawsone unleashed: A comprehensive review on chemistry, biosynthesis, and therapeutic potentials. Drug Design, Development and Therapy. 2024 Dec 31:3295-313. https://doi.org/10.2147/DDDT.S463545 PMid:39081702 PMCid:PMC11288359
14. Ríos J., Giner R., Marín M., Recio M. A pharmacological update of ellagic acid. Planta Med. 2018;84(15):1068-1093. https://doi.org/10.1055/a-0633-9492 PMid:29847844
15. Akram M, Imtiaz A, Soonmin H. Anti-Inflammatory Effects of Quercus and Other Health Benefits.
16. Jacob J, Gopalan R, Lakshmanaperumalsamy P, Illuri R, Bhosle D, Sangli GK, Mundkinajeddu D. Evaluation of Anti-psoriatic Potential of the Fruit Rind of Punica granatum L. Pharmacognosy Journal. 2019;11(3). https://doi.org/10.5530/pj.2019.11.73